AQQRF (Aquarius Surgical Technologies) Total Assets: $1.27 Mil (As of Dec. 2025)


What is Aquarius Surgical Technologies Total Assets?

Aquarius Surgical Technologies AQQRF Total Assets is $1.27 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

Aquarius Surgical Technologies's Total Assets for the quarter that ended in Dec. 2025 was $1.27 Mil.

During the past 12 months, Aquarius Surgical Technologies's average Total Assets Growth Rate was 270.70% per year. During the past 3 years, the average Total Assets Growth Rate was 38.10% per year. During the past 5 years, the average Total Assets Growth Rate was -2.20% per year. During the past 10 years, the average Total Assets Growth Rate was 22.50% per year.

During the past 13 years, Aquarius Surgical Technologies's highest 3-Year average Total Assets Growth Rate was 583.80%. The lowest was -72.70%. And the median was -12.30%.

Total Assets is connected with ROA %. Aquarius Surgical Technologies's annualized ROA % for the quarter that ended in Dec. 2025 was -118.06%. Total Assets is also linked to Revenue through Asset Turnover. Aquarius Surgical Technologies's Asset Turnover for the quarter that ended in Dec. 2025 was 0.01.

Aquarius Surgical Technologies  (OTCPK:AQQRF) Total Assets Explanation

Total Assets is connected with ROA %.

Aquarius Surgical Technologies's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=-1.696/( (1.608+1.265)/ 2 )
=-1.696/1.4365
=-118.06 %

Note: The Net Income data used here is four times the quarterly (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Aquarius Surgical Technologies's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=0.017/( (1.608+1.265)/ 2 )
=0.017/1.4365
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Aquarius Surgical Technologies Total Assets Related Terms

Aquarius Surgical Technologies Total Assets Historical Data

* Premium members only.

The historical data trend for Aquarius Surgical Technologies's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aquarius Surgical Technologies Total Assets Chart

Aquarius Surgical Technologies Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.75 0.71 0.50 0.42 1.36

Aquarius Surgical Technologies Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 1.36 2.07 1.61 1.27

Aquarius Surgical Technologies Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Aquarius Surgical Technologies's Total Assets for the fiscal year that ended in Mar. 2025 is calculated as

Total Assets=Total Equity (A: Mar. 2025 )+Total Liabilities (A: Mar. 2025 )
=-4.021+5.379
=1.36

Aquarius Surgical Technologies's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=-4.679+5.944
=1.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $1.27 Mil mean?
Aquarius Surgical Technologies (AQQRF) has a Total Assets of $1.27 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Aquarius Surgical Technologies and its competitors.
Is Aquarius Surgical Technologies' Total Assets too high?
Aquarius Surgical Technologies' current Total Assets is $1.27 Mil.
How does Aquarius Surgical Technologies' Total Assets compare to ABT and SYK?
Aquarius Surgical Technologies' Total Assets of $1.27 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Devices & Instruments company?
A good Total Assets depends on the Medical Devices & Instruments industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Aquarius Surgical Technologies and its competitors. Aquarius Surgical Technologies's current Total Assets is $1.27 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aquarius Surgical Technologies stock overvalued right now?
Aquarius Surgical Technologies (AQQRF) has a current Total Assets of $1.27 Mil. The current Total Assets is $1.27 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Aquarius Surgical Technologies (AQQRF), the current Total Assets is $1.27 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aquarius Surgical Technologies Business Description

Other Exchanges ASTI:Canada
Address 89 Scollard Street, Toronto, ON, CAN, M5R 1G4
Aquarius Surgical Technologies Inc is engaged in the development, sale, distribution, marketing, and exploitation of laser-driven technologies for use in surgical environments. Through its subsidiary, the company operates as an international distributor, service, and support organization providing integrated laser-based solutions across multiple medical disciplines. These disciplines include urology, gynecology, ophthalmology, thoracic, ENT, cardiovascular, and neurosurgery, many of which are now considered the standard of care for treatment. Geographically, the company generates maximum revenue from the sale of medical devices in the United States, and also has its presence in Canada.